University of Florida
Gainesville, Florida, 32610, United States
NCT Number: NCT04208269
Our project will assess the feasibility and estimate preliminary efficacy of a multilevel intervention to improve HPV vaccine series initiation among adolescents in Medicaid and CHIP. The investigators will use two intervention components: postcards and an iPad survey system. To estimate efficacy the investigators will select potential participants from Florida Medicaid and CHIP. The investigators will assess their claims for the HPV vaccine before and after the intervention.
Looking for future studies?
Notify Me11 year–18 year
All sexes
Interventional
Not applicable
Gainesville, Florida, 32610, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Post card sent to parent only
Accessed by adolescent and provider only
Time frame: Up to 5 months
The percent age eligible participants who initiate HPV vaccination.
Time frame: Up to 3 months
The percent age eligible participants received a preventive care visit
Looking for future studies?
Notify MeUniversity of Florida
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07259616
Cervical Intraepithelial Neoplasia, Cervix Carcinoma
View Trial DetailsNCT04199078
Cervix Lesion, Communicable Diseases
Donostia / San Sebastian, Guipuzcoa, Spain
View Trial DetailsNCT06205511
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Denver, Colorado, United States
View Trial DetailsNCT07768787
Cervical Carcinoma, Female Urogenital Diseases
Brussels, Belgium
View Trial Details